Cardiff Oncology, Inc. is an-related company in the biotechnology industry, whose stock has shown significant gains. 老虎证券 03-02 00:24 Protagenic Therapeutics, Inc.股价重挫15.24% 市值跌60.15万美元 Cardiff Oncology, Inc.涨幅较大,属于生物技术行业中的相关个股之一。关联...
添加自选 2.750 -0.120-4.18% 收盘价 04/04 16:00 (美东) 2.810 +0.060+2.18% 盘后19:49 (美东) 1.83亿总市值-2.89市盈率TTM 2.820最高价2.620最低价160.71万股成交量2.800今开2.870昨收437.31万成交额2.69%换手率亏损市盈率(静)6652.43万总股本5.66052周最高2.21市净率1.64亿流通值2.01052周最低--股息TTM59...
收盘价 03/28 16:00 (美东) 3.290 0.0000.00% 盘后20:01 (美东) 2.19亿总市值-3.46市盈率TTM 3.470最高价3.260最低价85.03万股成交量3.470今开3.440昨收281.32万成交额1.42%换手率亏损市盈率(静)6652.43万总股本6.38052周最高2.64市净率1.97亿流通值2.01052周最低--股息TTM5979.58万流通股81.480历史最高--股息...
Cardiff Oncology, Inc. Common Stock (CRDF) Earnings CRDF Termin der Jahreshauptversammlung Ergebnisbekanntgabe* für CRDF May 1, 2025Cardiff Oncology, Inc. Common Stock wird die Ergebnisse voraussichtlich bekanntgeben am 05/01/2025. Das Datum der anstehenden Bekanntgabe der Geschäftsergebnis...
Implied Stock Price 30.43 43.04 3.57 1.55 20.14 3.95 FX Conversion Rate to Trading Currency 1.00 1.00 1.00 1.00 1.00 1.00 Implied Stock Price (Trading Cur) 30.43 43.04 3.57 1.55 20.14 3.95 Trading Currency USD USD USD USD USD USD FX Rate to Reporting Currency 1.00 1.00 1.00 1.00 1.00 1.00保...
Spreads Protection Strategies Straddles & Strangles Horizontal Spreads Butterfly Spreads Condor Strategies company News & Headlines Key Statistics SEC Filings Competitors Stock Comparison Insider Trades analysts Earnings Estimates Analyst Ratings financials Financial Summary Income Statement Balance Sheet Cash Flow...
Spreads Protection Strategies Straddles & Strangles Horizontal Spreads Butterfly Spreads Condor Strategies company News & Headlines Key Statistics SEC Filings Competitors Stock Comparison Insider Trades analysts Earnings Estimates Analyst Ratings financials Financial Summary Income Statement Balance Sheet Cash Flow...
营业净利润率 -1,256.08% 总资产周转率 0.007 资产负债率 0.147 净利润 -857.90 营业收入 68.30 营业收入 68.30 资产总额 9,719.00 负债总额 1,424.10 资产总额 9,719.00 收入总额 64.40 成本总额 922.30 流动资产 9,505.40 非流动资产 213.60 营业收入 68.30 公允价值变动损益 - 资产处理损...
HC Wainwright & Co.:维持Cardiff Oncology(CRDF.US)评级,由买入调整至买入评级, 目标价由13.00美元调整至17.00美元。 Cardiff Oncology(CRDF.US)公司简介:Cardiff Oncology Inc是一家临床阶段的生物技术公司,利用PLK1抑制(一种经过充分验证的肿瘤药物靶点)开发针对一系列癌症的新疗法,以满足最大的医疗需求。该公司专注...
2.64亿总市值-4.18市盈率TTM 3.990最高价3.460最低价149.54万股成交量3.480今开3.450昨收570.27万成交额2.61%换手率亏损市盈率(静)6651.84万总股本6.42052周最高5.34市净率2.28亿流通值1.44052周最低--股息TTM5737.83万流通股81.480历史最高--股息率TTM15.36%振幅0.450历史最低3.813平均价1股每手 ...